Cocrystal Pharma (COCP) P/E Ratio
P/E Ratio as of Jul 1, 2025: -0.96
Average-1.01
Median-0.9900
Minimum-1.08
Maximum-0.9400
-0.96
Past Month+0.14 (12.73%)
The P/E ratio for Cocrystal Pharma (COCP) is -0.96 as of Jul 1, 2025. This represents a decrease of -4.95% compared to its 12-month average P/E ratio of -1.01. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Cocrystal Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Cocrystal Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Cocrystal Pharma to industry peers.
Cocrystal Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Cocrystal Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Cocrystal Pharma to industry peers.
Cocrystal Pharma (COCP) P/E Ratio Insights
See Cocrystal Pharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Cocrystal Pharma (COCP)
Order type
Buy in
Order amount
Est. shares
0 shares
Cocrystal Pharma (COCP) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $1.49 | -0.96 |
| Jun 2, 2025 | $1.65 | -1.06 |
| May 1, 2025 | $1.58 | -0.92 |
| Apr 1, 2025 | $1.42 | -0.83 |
| Mar 3, 2025 | $1.79 | -0.97 |
| Feb 3, 2025 | $1.87 | -1.02 |
| Jan 2, 2025 | $2.32 | -1.26 |
Cocrystal Pharma (COCP) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.96 | -12.73% |
| 2024 | -1.10 | +27.91% |
| 2023 | -0.86 | +437.50% |
| 2022 | -0.16 | -96.05% |
| 2021 | -4.05 | -45.71% |
| 2020 | -7.46 | — |
FAQs About Cocrystal Pharma (COCP) P/E ratio
The latest P/E ratio of Cocrystal Pharma (COCP) is -0.96, as of Jul 1, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Cocrystal Pharma’s last 12-month average P/E ratio is -1.01, compared to its current P/E ratio of -0.96. This reflects a decrease of -4.95%.
Cocrystal Pharma’s current P/E ratio of -0.96 is lower than its last 12-month average P/E of -1.01. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Cocrystal Pharma’s average P/E ratio over the last 3 years is -0.74. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Cocrystal Pharma’s average P/E ratio over the last 5 years is -2.39. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.